Compare IPI & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPI | BWAY |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.8M | 450.8M |
| IPO Year | 2007 | N/A |
| Metric | IPI | BWAY |
|---|---|---|
| Price | $38.81 | $15.89 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $25.00 | $13.25 |
| AVG Volume (30 Days) | ★ 263.9K | 139.1K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.14 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $298,328,000.00 | N/A |
| Revenue This Year | $5.01 | $309.69 |
| Revenue Next Year | N/A | $26.21 |
| P/E Ratio | ★ $43.85 | $81.98 |
| Revenue Growth | ★ 17.13 | N/A |
| 52 Week Low | $22.55 | $8.61 |
| 52 Week High | $50.34 | $26.63 |
| Indicator | IPI | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 54.62 |
| Support Level | $37.00 | $14.56 |
| Resistance Level | $47.78 | $16.63 |
| Average True Range (ATR) | 1.38 | 0.62 |
| MACD | -0.02 | 0.28 |
| Stochastic Oscillator | 76.37 | 73.44 |
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, where the firm's production facilities are located.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.